H. Schouten

1.1k total citations
36 papers, 753 citations indexed

About

H. Schouten is a scholar working on Hematology, Genetics and Physiology. According to data from OpenAlex, H. Schouten has authored 36 papers receiving a total of 753 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Hematology, 14 papers in Genetics and 11 papers in Physiology. Recurrent topics in H. Schouten's work include Hemoglobinopathies and Related Disorders (10 papers), Erythrocyte Function and Pathophysiology (6 papers) and Chronic Myeloid Leukemia Treatments (5 papers). H. Schouten is often cited by papers focused on Hemoglobinopathies and Related Disorders (10 papers), Erythrocyte Function and Pathophysiology (6 papers) and Chronic Myeloid Leukemia Treatments (5 papers). H. Schouten collaborates with scholars based in Curacao, Netherlands and France. H. Schouten's co-authors include L.W. Statius van Eps, Anne Boudier, Anna Sureda, A. J. M. Donker, Paul E. de Jong, George D. Nicholson, George A.O. Alleyne, Giorgio Dini, Jakob Passweg and Per Ljungman and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Kidney International.

In The Last Decade

H. Schouten

33 papers receiving 698 citations

Peers

H. Schouten
D. H. Berry United States
GP Herzig United States
Sherwood P. Miller United States
Itai Levi Israel
Hans L. Haak Netherlands
Stephen Chang United States
Steven Andrèsen United States
H. Schouten
Citations per year, relative to H. Schouten H. Schouten (= 1×) peers Giuseppe Papa

Countries citing papers authored by H. Schouten

Since Specialization
Citations

This map shows the geographic impact of H. Schouten's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. Schouten with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. Schouten more than expected).

Fields of papers citing papers by H. Schouten

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H. Schouten. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. Schouten. The network helps show where H. Schouten may publish in the future.

Co-authorship network of co-authors of H. Schouten

This figure shows the co-authorship network connecting the top 25 collaborators of H. Schouten. A scholar is included among the top collaborators of H. Schouten based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H. Schouten. H. Schouten is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Schouten, H., et al.. (2015). Non-myeloablative allogeneic stem cell transplantation: a new treatment option for acquired angioedema?. PubMed. 73(8). 383–5. 1 indexed citations
2.
Montoto, Silvia, Paolo Corradini, Martin Dreyling, et al.. (2013). Indications for hematopoietic stem cell transplantation in patients with follicular lymphoma: a consensus project of the EBMT-Lymphoma Working Party. Haematologica. 98(7). 1014–1021. 66 indexed citations
3.
Canals, Carmen, H. Schouten, Arnon Nagler, et al.. (2009). Allogeneic stem cell transplantation as salvage therapy in patients with diffuse large B-cell non-Hodgkin's lymphoma relapsing after an autologous stem cell transplantation. An analysis of the EBMT Registry. Bone Marrow Transplantation. 43. 2 indexed citations
4.
Ljungman, Per, Álvaro Urbano-Ispizúa, Marina Cavazzana, et al.. (2006). Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: definitions and current practice in Europe. Bone Marrow Transplantation. 37(5). 439–449. 157 indexed citations
5.
Huugen, Dennis, H. Schouten, & Gerard M.J. Bos. (2002). Advantages and limitations of (non-)myeloablative allogeneic stem cell transplantation.. PubMed. 60(4). 162–9. 3 indexed citations
6.
Huugen, Dennis, Gerard M.J. Bos, Marc H.A. Jansen, et al.. (2002). Non-myeloablative allogeneic stem cell transplantation in patients with solid tumours and patients with a haematological malignancy.. PubMed. 60(4). 170–3. 1 indexed citations
7.
Peters, Florian, M. Fickers, Frans Erdkamp, et al.. (2001). The effect of optimal treatment on elderly patients with aggressive non-Hodgkin's lymphoma: more patients treated with unaffected response rates. Annals of Hematology. 80(7). 406–410. 20 indexed citations
8.
Dekker, A. W., Mars B. vanʼt Veer, W Sizoo, et al.. (1997). Intensive postremission chemotherapy without maintenance therapy in adults with acute lymphoblastic leukemia. Dutch Hemato-Oncology Research Group.. Journal of Clinical Oncology. 15(2). 476–482. 49 indexed citations
9.
Vries, Elisabeth G.E. de, Sjoerd Rodenhuis, H. Schouten, et al.. (1996). Phase II study of intensive chemotherapy with autologous bone marrow transplantation in patients in complete remission of disseminated breast cancer. Breast Cancer Research and Treatment. 39(3). 307–313. 14 indexed citations
10.
Hupperets, P., Lex Volovics, Leo J. Schouten, et al.. (1993). Adjuvant chemohormonal therapy with cyclophosphamide, doxorubicin and 5-fluorouracil (CAF) with or without medroxyprogesterone acetate for node-positive breast cancer patients. Annals of Oncology. 4(4). 295–301. 17 indexed citations
11.
Loosveld, O. J. L., et al.. (1992). Invasive Aspergillus infections in patients with a malignancy: description of an outbreak and overview of the literature.. PubMed. 40(1-2). 62–8. 5 indexed citations
12.
Schouten, H., Warren G. Sanger, & J. O. Armitage. (1991). Chromosomal Abnormalities in Malignant Lymphoma and Hodgkin's Disease. Leukemia & lymphoma. 5(2-3). 93–100. 6 indexed citations
13.
Jong, P.E. de, et al.. (1982). The Influence of Indomethacin on Renal Concentrating and Diluting Capacity in Sickle Cell Nephropathy. Clinical Science. 63(1). 53–58. 18 indexed citations
14.
Jong, Paul E. de, et al.. (1980). The Influence of Indomethacin on Renal Haemodynamics in Sickle Cell Anaemia. Clinical Science. 59(4). 245–250. 48 indexed citations
15.
Alleyne, George A.O., et al.. (1975). The kidney in sickle cell anemia. Kidney International. 7(6). 371–379. 49 indexed citations
16.
Goossens, Jolien, et al.. (1972). Incomplete renal tubular acidosis in sickle cell disease. Clinica Chimica Acta. 41. 149–156. 30 indexed citations
17.
Schouten, H., et al.. (1971). Transketolase in sickle cell anemia. Clinica Chimica Acta. 31(2). 487–488.
18.
Schouten, H., et al.. (1964). GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY IN RED CELLS. INCIDENCE IN THE CURA CAO POPULATION, ITS CLINICAL AND GENETIC ASPECTS.. PubMed. 27. 289–310. 11 indexed citations
19.
Schouten, H., L.W. Statius van Eps, & Anne Boudier. (1964). Transketolase in blood. Clinica Chimica Acta. 10(5). 474–476. 76 indexed citations
20.
Schouten, H., et al.. (1963). D-Xylose in blood and urine. Clinica Chimica Acta. 8(6). 970–971. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026